Biogen says uptake on new Alzheimer’s drug slower than expected

Biogen Inc (BIIB.O) on Thursday said getting hospitals and clinics to use its new Alzheimer’s disease drug Aduhelm and insurers to reimburse it has been slower than it expected, as controversy mounts over the U.S. Food and Drug Administration’s approval process for the treatment. The Cambridge, Massachusetts-based drugmaker’s top scientist also defended the science behind […]

Continue Reading

Amazon-backed Rivian confirms plan for second U.S. assembly plant

Amazon.com Inc backed electric vehicle startup Rivian Automotive plans to build a second U.S. assembly plant that will also include battery cell production, according to four people familiar with the matter. “While it’s early in an evolving process, Rivian is exploring locations for a second U.S. manufacturing facility,” Rivian spokeswoman Amy Mast said on Thursday. […]

Continue Reading

Volkswagen investors approve $339 mln settlement with former execs

Shareholders in Europe’s largest carmaker Volkswagen (VOWG_p.DE) on Thursday approved a deal to settle claims against four former executives, including long-time CEO Martin Winterkorn, related to the company’s emissions scandal. The initial deal, which was announced last month and which will see Volkswagen receive 288 million euros ($339 million) in compensation, required shareholder approval and […]

Continue Reading

Car parts maker Valeo confirms outlook, expects chip shortage to ease

French car parts maker Valeo on Thursday confirmed its 2021 financial outlook as it posted increased first-half sales and profit, adding it expected the shortage of key technology chips to ease. Valeo’s first-half earnings before interest, tax, depreciation and amortisation (EBITDA) rose to 1.21 billion euros ($1.41 billion) from 202 million a year earlier, while […]

Continue Reading